drugset / Trial / NCT05036291
A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB004 Administered as Monotherapy or Combination Therapy in Subjects with Advanced Solid Tumors
Timeline
- Start
- 2021-10-01
- Primary completion
- 2025-09-24
- Completion
- 2025-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NB004 | Unknown | — | Oral |
| Background | Sotorasib | Small molecule | — | — |